In 2015, a quantitative pyrosequencing methylation screening applied to 79 CRC and 22 healthy colon samples evidenced differences in the methylation status of the DUSP9 promoter, although no conclusion could be drawn regarding the role of DUSP9 promoter methylation in colon carcinogenesis [77]. This evidence concerns the gene DUSP9 and colorectal carcinoma.